Leadership Team

Chief Executive Officer

David Jiménez is the Chief Executive Officer of CENTOGENE, bringing over 25 years of leadership experience in CEO roles within the life sciences and healthcare sectors. He is also a co-founder and investor in several startups in the field of reproductive health, and serves as a board member and advisor to multiple healthcare companies.

Previously, David served as CEO of a biotechnology company in the reproductive health space, where he led its transformation from an early-stage startup into a global leader with operations across more than 20 countries. Under his leadership, the company scaled to over €130M in annual revenue and achieved a successful exit valued at over €1 billion.

With a strong commercial mindset, David excels at driving global growth through strategic vision and execution. He brings deep expertise in start-up leadership, business development, and go-to-market strategy, consistently delivering results in high-growth environments. David holds an MBA and a degree in Business Management from ESADE, with international studies in finance and strategy at CEMS (Université catholique de Louvain) and IESE Business School.

Chief Medical and Genomic Officer

Prof. Peter Bauer, M.D., serves as CENTOGENE’s Chief Medical and Genomic Officer, where he combines clinical and medical understanding in genetic testing with an excellent knowledge of the latest scientific development, based on his extraordinary experience, especially in high-throughput genetic testing using next-generation sequencing. He received his board certification in Human Genetics in 2006 and headed the molecular diagnostic laboratory at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen. Additionally, he is Vice President of the German Society of Neurogenetics (DGNG). Peter has authored more than 250 publications in neurogenetics, oncogenetics, cardiogenetics, and sequencing technology.

Chief Financial Officer

Francisco Valor is a senior executive with over 20 years of international experience as Chief Financial Officer in publicly listed and private equity-backed companies, healthcare groups, and startups. He leverages finance as a strategic driver to enhance business performance, with expertise in financial planning, M&A, funding, crisis management, and Business Intelligence.

In addition to his CFO roles, he has served as Managing Director for operations in Eastern Europe and the Middle East – bringing a strong global perspective and business-oriented approach.

He holds an Executive MBA from IESE Business School, along with advanced degrees in Financial Audit and Business Administration.

Chief Commercial Officer

Víctor Llinares serves as Chief Commercial Officer at CENTOGENE, where he leads the company’s global sales strategy across all business areas, including clinical diagnostics, pharmaceutical partnerships, and reproductive health. With over a decade of experience heading international business development teams in the genetics space—and more than 20 years in senior executive roles overseeing operations, sales, and affiliate management—Víctor brings deep industry expertise and a strategic mindset. He holds a degree in Industrial Engineering, along with postgraduate qualifications in Business Administration from IESE and Marketing from IE.

CEO CENTOGENE Brazil and Latin America

Marcia Riboldi is the CEO of CENTOGENE Brazil and Latin America, where she leads the company’s strategy, business development, and scientific operations across the region. With over 15 years of experience in reproductive genetics, innovation, and research, Marcia combines deep technical expertise with a strategic, growth-oriented mindset. She holds a PhD in Gynecology and Obstetrics, is a trained biomedical scientist, and has a specialization in Genetics. In recent years, she has increasingly focused on business development and market expansion. Prior to joining CENTOGENE, she served as VP for Latin America, driving the development of the reproductive genetics market and leading cultural transformation of teams following mergers and acquisitions. She is also the founder of a startup dedicated to female empowerment.

Chief Executive Officer, Asia Pacific

Andy Chang serves as Chief Executive Officer, Asia Pacific, at CENTOGENE. In this role, he is responsible for shaping the company’s strategic direction and accelerating growth across one of the world’s most dynamic healthcare markets. By strengthening partnerships and expanding access to CENTOGENE’s innovative genetic diagnostics and precision medicine solutions, Andy is committed to delivering tangible impact for patients and healthcare systems throughout the region.

With more than 15 years of leadership experience spanning genomics, diagnostics, and life sciences, Andy has successfully driven commercial expansion, business development, and cross-regional collaboration. Holding a PhD in Biology and an Executive MBA, he brings a distinctive combination of scientific depth and business leadership. His multicultural and multilingual background further enhances his ability to build bridges across diverse markets and stakeholders. This unique perspective enables him to connect groundbreaking genomic science with practical healthcare solutions — transforming complex insights into real-world outcomes and sustainable growth.

Chief Information Officer

Daniel Seguí serves as CENTOGENE’s Chief Information Officer, where he is responsible for shaping and executing the company’s global IT strategy. With extensive experience in digital transformation, enterprise architecture, cybersecurity, and cloud operations, he plays a key role in enabling CENTOGENE’s services through secure, scalable, and business-aligned technology platforms. With over two decades of experience in senior IT leadership roles, Daniel has led global multicultural teams and technology organizations across the biotechnology, healthcare, and food manufacturing industries. His work has spanned infrastructure modernization, ERP and LIMS integration, regulatory compliance, and the implementation of innovative, data-driven systems to support scientific and operational excellence.

Daniel holds a degree in Telecommunications Engineering from the Universitat Politècnica de València (UPV). He brings a deep technical foundation, combined with a strategic mindset, to bridge business needs with technology-driven innovation

Chief Technology Officer

Dr. Krishna Kumar Kandaswamy is Chief Technology Officer at CENTOGENE, where he leads technology strategy and innovation across bioinformatics, AI, software engineering, and clinical diagnostics. With more than 19 years of experience in computational biology and precision medicine, he has built and led international teams and has played a key role in advancing multiomics, rare disease diagnostics, and reproductive genetics solutions. Before becoming CTO, he held several senior leadership roles at CENTOGENE, including Vice President of R&D Bioinformatics, and earlier conducted research at the Max Planck Institute in Germany. He holds a Ph.D. in Computational Biology from the University of Lübeck, Germany and has authored more than 50 scientific publications spanning genomics, Bioinformatics, AI, biomarker discovery, and rare diseases

Chief Operating Officer

Chief Growth and Execution Officer

Aakanksha Malik-Nair is a dynamic and visionary executive with over 15 years of global leadership experience across financial strategy, transformation, and growth execution. Currently serving as Chief Growth and Execution Officer at CENTOGENE, she drives strategic initiatives and operational excellence, building on a robust foundation that includes senior roles such as Vice President of FP&A and Director of Finance Transformation. Renowned for her ability to deliver innovative financial solutions and lead high-performing teams, Aakanksha has steered complex cross-border M&A, driven government-level economic development, and earned accolades including recognition as one of Mail & Guardian’s Top 200 South African Young Leaders. Coming from an investment banking background, her experience spans in both public and private sectors. Holding an MBA and qualifications from London School of Economics, and multiple Universities namely North Carolina, Cape Town and Stellenbosch, she blends technical depth with strategic foresight to create sustainable value across industries.